Multi-stage delivery nano-particle systems for therapeutic applications - Wikidata - wikimedia - TriplyDB

Multi-stage delivery nano-particle systems for therapeutic applications

Multi-stage delivery nano-particle systems for therapeutic applications

http://www.wikidata.org/entity/Q34166491

about

Multifunctional iron platinum stealth immunomicelles: targeted detection of human prostate cancer cells using both fluorescence and magnetic resonance imaging Nanomedicine concepts in the general medical curriculum: initiating a discussion Convergence of nanotechnology and cancer prevention: are we there yet?Biocompatibility assessment of Si-based nano- and micro-particles Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in mice Silicon particles as trojan horses for potential cancer therapy.Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors.Characterization of Free and Porous Silicon-Encapsulated Superparamagnetic Iron Oxide Nanoparticles as Platforms for the Development of Theranostic Vaccines.Nanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections.Cancer cell invasion: treatment and monitoring opportunities in nanomedicine.Redirecting Transport of Nanoparticle Albumin-Bound Paclitaxel to Macrophages Enhances Therapeutic Efficacy against Liver Metastases Downregulation of indoleamine-2,3-dioxygenase in cervical cancer cells suppresses tumor growth by promoting natural killer cell accumulation Indoleamine-2,3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapy Biotargeted nanomedicines for cancer: six tenets before you begin Preparation, characterization, and cellular associations of silicon logic-embedded vectors Multistage nanoparticles for improved delivery into tumor tissue Porous silicon advances in drug delivery and immunotherapy.Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer.Best practices in cancer nanotechnology: perspective from NCI nanotechnology alliance.Biomolecule delivery to engineer the cellular microenvironment for regenerative medicine.Nanomedicine: application areas and development prospects.Particle platforms for cancer immunotherapy.Recent advances in porous silicon technology for drug delivery.Non-Viral Delivery and Therapeutic Application of Small Interfering RNAs.Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications.Nanotechnology applications in diagnosis and treatment of metastasis.Mathematical modeling analysis of intratumoral disposition of anticancer agents and drug delivery systems.Porous silicon for drug delivery applications and theranostics: recent advances, critical review and perspectives.The Emerging Role of Nanotechnology in Cell and Organ Transplantation.Two-Dimensional Nanomaterials for Biomedical Applications: Emerging Trends and Future Prospects.Silica nanoparticles induce cardiotoxicity interfering with energetic status and Ca2+ handling in adult rat cardiomyocytes.Polymeric microspheres as protein transduction reagents.Bottom-Up Instructive Quality Control in the Biofabrication of Smart Protein Materials.Mechanisms of cooperation in cancer nanomedicine: towards systems nanotechnology.Enhanced gene delivery in porcine vasculature tissue following incorporation of adeno-associated virus nanoparticles into porous silicon microparticles.Thrombin generation assay and transmission electron microscopy: a useful combination to study tissue factor-bearing microvesicles.Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium.Low pressure mediated enhancement of nanoparticle and macromolecule loading into porous silicon structures.A functional nanocarrier that copenetrates extracellular matrix and multiple layers of tumor cells for sequential and deep tumor autophagy inhibitor and chemotherapeutic delivery.Chitosan supraparticles with fluorescent silica nanoparticle shells and nanodiamond-loaded cores

P2860

Q24634139-684783B4-A3CE-4BBA-AF7C-10655B471C34 Q26775137-1A8EFCBD-C126-4756-89AC-26CBC92C2BEC Q28386699-29FC73AC-AEBF-47FE-8CB9-006538DF416E Q28389467-04B7C4A8-B0BC-46F1-A8DF-67963C57C7F4 Q28486624-095920BC-61D3-4D43-A419-F01AA83BB9C4 Q30412166-19C75031-5C75-4549-A82E-D9BA9D53A632 Q30425859-90E0A023-DCAF-422A-B854-506554773589 Q33752929-4914405C-92CD-476C-9312-F38B21F6C5FC Q33935474-04FC7A5B-6F1D-46C4-8A3F-2CEC029591EF Q35093966-4503D1E5-D215-4513-88F2-7B49BE78D65D Q36471409-0797C1A4-15AA-49D8-AEA6-97D4E33670B0 Q36642844-CBA8F0EB-73C1-4C0D-BA6E-02208A42BC59 Q36646476-F70E4FB5-D23C-4C7B-94BB-00807096F891 Q36814280-67E2AC10-3021-4550-906D-145707047F73 Q37148412-1561E9CA-1A75-478C-9E46-4C6DB5457FD5 Q37176313-CE3F82E2-6F1C-41B6-B2EB-1C6E9F7638F6 Q37227659-A7156DD8-F592-456F-AF61-9FA09B4C1A94 Q37302933-B6B18EA0-CF32-466C-B5AD-741590F6ABA7 Q37561973-28EC7633-3579-49F6-8955-D2BFCF477660 Q37735550-519A2D6A-CCDD-4263-901D-4F8018249736 Q37891690-FAB8D48D-E265-4D2C-AE10-5301BB7A9488 Q38114060-0D350C94-5B27-491D-8DB8-75D2A831F31A Q38123855-B87BCE78-2996-408C-B819-E287AF48960A Q38168518-9E0DDFF5-889C-4AB9-BBE8-5B3E95DCBFC1 Q38208617-1F918FA1-E0DB-4CFA-B054-C77768335163 Q38254086-C31851F1-06D2-499B-8F1F-F02BE134C13D Q38392523-56D9851E-CF42-45A4-9074-DCCCA6B958A7 Q38732021-46066BBA-C4F6-4D96-81A7-1E077EF5FB56 Q38852662-4CC2E301-20FA-483F-8F72-55279F542AC4 Q38954326-DCCA59E0-8CE0-4091-B05F-42C7A0ECCEBE Q38994567-1DB8A111-66AA-4286-A055-8C8E311491A9 Q40373344-ADE36FF9-2983-4968-BF62-FA730A21FDBE Q40384339-DB843DA1-DC85-46BD-8BAE-25B534977C14 Q42145728-4AFBC4B5-B1D8-4512-A4F5-57EE6B49DDA0 Q42194547-661C990E-F2F6-4B24-AFF6-9FD3FECE7ECA Q42248974-B043C40A-C0BD-4EAB-A4C1-EDE94ED89415 Q42380474-8787EDC0-7176-4251-A711-1D6CF85D0DEF Q43054291-F06B4E1D-1802-4637-9055-9DF867CCBB13 Q46129533-BAFCDE4A-5712-47C3-A6FC-1F4A3388D387 Q57367594-1FCEA78E-A722-4BCC-9470-6FC5BDED2508

P2860

Multi-stage delivery nano-particle systems for therapeutic applications

http://www.wikidata.org/entity/Q34166491

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Multi-stage delivery nano-particle systems for therapeutic applications

@ast

Multi-stage delivery nano-particle systems for therapeutic applications

@en

Multi-stage delivery nano-particle systems for therapeutic applications

@nl

type

label

Multi-stage delivery nano-particle systems for therapeutic applications

@ast

Multi-stage delivery nano-particle systems for therapeutic applications

@en

Multi-stage delivery nano-particle systems for therapeutic applications

@nl

prefLabel

Multi-stage delivery nano-particle systems for therapeutic applications

@ast

Multi-stage delivery nano-particle systems for therapeutic applications

@en

Multi-stage delivery nano-particle systems for therapeutic applications

@nl

P1433

Q34166491-C703F588-B5C1-4340-B38A-89B6D54BE543

P1476

Q34166491-AC9AA552-1042-48BC-8DA7-A096CA266B65

P2093

Q34166491-1185A66D-B30F-4A1E-9D6B-DD52CE8B24B8

Q34166491-18826EA2-CEF5-4675-9AE2-34030908C406

Q34166491-3B1BAE7B-EEA5-4DD9-81FE-87C0A0AABD9C

Q34166491-834613B1-69AC-498E-838C-15726CDC8AF4

P2860

Q34166491-013B5455-7F25-4032-A1E5-05B141AE5C8E

Q34166491-04423E32-45ED-4E29-A866-11A7F3E3F42C

Q34166491-12C923B0-62C7-4468-889A-6D2B2B2447ED

Q34166491-13D4DC1A-282E-48B7-ADBC-651600A88413

Q34166491-149D0C6A-098A-488E-94D2-2BD35B6E87A2

Q34166491-160A8B77-CDC7-48A9-B953-46DF6E11C40E

Q34166491-213FAA3E-D5ED-4DC4-9FED-1A0A49184350

Q34166491-24D9EE6E-289D-4918-BCCC-7404CA132D81

Q34166491-259A4E4F-71F2-468B-B218-F92B312E8A32

Q34166491-2B52BE79-F08A-45CD-994B-2F9ED054D90D

P304

Q34166491-50C21675-4454-4BD3-81A6-503B52C0ABE4

P31

Q34166491-903CEE0E-CDD0-4574-93A5-E65DBC505FB8

P356

Q34166491-325EB031-0E66-4BEC-9521-509FB92797B5

P407

Q34166491-F32CCE02-A405-4457-B1EB-A9218917F608

P433

Q34166491-FAAB11CD-8EB8-4634-9BAD-CD10359FD6A4

P478

Q34166491-D95A6C28-2A37-4BE5-8BAE-20CDC84945A5

P50

Q34166491-e95131e9-475d-02d3-0a77-d2e263fe2c08

P577

Q34166491-FE66112D-0B0E-4EF8-8F51-6D7B5253B603

P5875

Q34166491-48E10774-D688-47BB-8B4A-995887AD8718

P698

Q34166491-42582C0B-E43C-458B-8AAE-CC2EA80716DD

P932

Q34166491-EAEABA4D-DEB2-461B-874D-185472D63810

P356

J.BBAGEN.2010.05.004

P1433

Biochimica et Biophysica Acta

P1476

Multi-stage delivery nano-particle systems for therapeutic applications

@en

P2093

Biana Godin

http://www.w3.org/2001/XMLSchema#string

Ciro Chiappini

http://www.w3.org/2001/XMLSchema#string

Mauro Ferrari

http://www.w3.org/2001/XMLSchema#string

Rita E Serda

http://www.w3.org/2001/XMLSchema#string

P2860

Openings between defective endothelial cells explain tumor vessel leakiness

The emerging nanomedicine landscape

Cancer nanotechnology: opportunities and challenges

Recent advances with liposomes as pharmaceutical carriers

Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates.

Nanotechnology and cancer.

Quantitative mechanics of endothelial phagocytosis of silicon microparticles.

Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly(gamma-benzyl L-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety.

Combinatorial selection and delivery of thioaptamers.

Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer.

P304

317-329

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBAGEN.2010.05.004

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

1810

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-05-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44622128

http://www.w3.org/2001/XMLSchema#string

P698

20493927

http://www.w3.org/2001/XMLSchema#string

P932

2948075

http://www.w3.org/2001/XMLSchema#string